vs
MEDICAL PROPERTIES TRUST INC（MPW）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
MEDICAL PROPERTIES TRUST INC的季度营收约是Orthofix Medical Inc.的1.2倍（$270.3M vs $219.9M），MEDICAL PROPERTIES TRUST INC净利率更高（6.5% vs -1.0%，领先7.5%），MEDICAL PROPERTIES TRUST INC同比增速更快（16.6% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -0.2%）
Medical Properties Trust, Inc.（MPT）是一家总部位于美国阿拉巴马州伯明翰的跨国房地产投资信托基金（REIT），主要在美欧地区收购、投资医疗保健设施与营利性医疗控股公司，资产收购多采用售后回租模式，原业主出售资产后成为其租户，租户通常需签署长期三净租赁协议。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MPW vs OFIX — 直观对比
营收规模更大
MPW
是对方的1.2倍
$219.9M
营收增速更快
MPW
高出14.6%
2.0%
净利率更高
MPW
高出7.5%
-1.0%
两年增速更快
OFIX
近两年复合增速
-0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.3M | $219.9M |
| 净利润 | $17.6M | $-2.2M |
| 毛利率 | 95.8% | 71.1% |
| 营业利润率 | 9.7% | 0.2% |
| 净利率 | 6.5% | -1.0% |
| 营收同比 | 16.6% | 2.0% |
| 净利润同比 | 104.3% | 92.4% |
| 每股收益（稀释后） | $0.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPWOFIX
| Q4 25 | $270.3M | $219.9M | ||
| Q3 25 | $237.5M | $205.6M | ||
| Q2 25 | $240.4M | $203.1M | ||
| Q1 25 | $223.8M | $193.6M | ||
| Q4 24 | $231.8M | $215.7M | ||
| Q3 24 | $225.8M | $196.6M | ||
| Q2 24 | $266.6M | $198.6M | ||
| Q1 24 | $271.3M | $188.6M |
净利润MPWOFIX
| Q4 25 | $17.6M | $-2.2M | ||
| Q3 25 | $-77.7M | $-22.8M | ||
| Q2 25 | $-98.4M | $-14.1M | ||
| Q1 25 | $-118.3M | $-53.1M | ||
| Q4 24 | $-412.3M | $-29.1M | ||
| Q3 24 | $-801.2M | $-27.4M | ||
| Q2 24 | $-320.6M | $-33.4M | ||
| Q1 24 | $-875.6M | $-36.0M |
毛利率MPWOFIX
| Q4 25 | 95.8% | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | 91.8% | 68.7% | ||
| Q1 25 | 63.6% | 62.8% | ||
| Q4 24 | 90.9% | 69.0% | ||
| Q3 24 | 96.5% | 68.7% | ||
| Q2 24 | 98.4% | 67.8% | ||
| Q1 24 | 84.9% | 67.5% |
营业利润率MPWOFIX
| Q4 25 | 9.7% | 0.2% | ||
| Q3 25 | -28.0% | -8.3% | ||
| Q2 25 | -36.7% | -7.9% | ||
| Q1 25 | -48.5% | -25.2% | ||
| Q4 24 | -173.7% | -5.3% | ||
| Q3 24 | -350.7% | -9.6% | ||
| Q2 24 | -114.5% | -12.5% | ||
| Q1 24 | -318.6% | -15.6% |
净利率MPWOFIX
| Q4 25 | 6.5% | -1.0% | ||
| Q3 25 | -32.7% | -11.1% | ||
| Q2 25 | -40.9% | -6.9% | ||
| Q1 25 | -52.8% | -27.4% | ||
| Q4 24 | -177.8% | -13.5% | ||
| Q3 24 | -354.8% | -13.9% | ||
| Q2 24 | -120.3% | -16.8% | ||
| Q1 24 | -322.7% | -19.1% |
每股收益（稀释后）MPWOFIX
| Q4 25 | $0.03 | $-0.05 | ||
| Q3 25 | $-0.13 | $-0.57 | ||
| Q2 25 | $-0.16 | $-0.36 | ||
| Q1 25 | $-0.20 | $-1.35 | ||
| Q4 24 | $-0.68 | $-0.76 | ||
| Q3 24 | $-1.34 | $-0.71 | ||
| Q2 24 | $-0.54 | $-0.88 | ||
| Q1 24 | $-1.46 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $540.9M | $82.0M |
| 总债务越低越好 | $9.7B | — |
| 股东权益账面价值 | $4.6B | $450.0M |
| 总资产 | $15.0B | $850.6M |
| 负债/权益比越低杠杆越低 | 2.11× | — |
8季度趋势，按日历期对齐
现金及短期投资MPWOFIX
| Q4 25 | $540.9M | $82.0M | ||
| Q3 25 | $396.6M | $62.9M | ||
| Q2 25 | $509.8M | $65.6M | ||
| Q1 25 | $673.5M | $58.0M | ||
| Q4 24 | $332.3M | $83.2M | ||
| Q3 24 | $275.6M | $30.1M | ||
| Q2 24 | $606.5M | $26.4M | ||
| Q1 24 | $224.3M | $27.0M |
总债务MPWOFIX
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | $157.2M | ||
| Q2 25 | $9.6B | $157.0M | ||
| Q1 25 | $9.5B | $156.9M | ||
| Q4 24 | $8.8B | $157.0M | ||
| Q3 24 | $9.2B | $118.5M | ||
| Q2 24 | $9.4B | $118.0M | ||
| Q1 24 | $10.1B | $118.2M |
股东权益MPWOFIX
| Q4 25 | $4.6B | $450.0M | ||
| Q3 25 | $4.7B | $442.5M | ||
| Q2 25 | $4.8B | $458.3M | ||
| Q1 25 | $4.8B | $458.3M | ||
| Q4 24 | $4.8B | $503.1M | ||
| Q3 24 | $5.4B | $525.9M | ||
| Q2 24 | $6.2B | $546.0M | ||
| Q1 24 | $6.7B | $570.3M |
总资产MPWOFIX
| Q4 25 | $15.0B | $850.6M | ||
| Q3 25 | $14.9B | $832.6M | ||
| Q2 25 | $15.2B | $837.2M | ||
| Q1 25 | $14.9B | $823.1M | ||
| Q4 24 | $14.3B | $893.3M | ||
| Q3 24 | $15.2B | $867.9M | ||
| Q2 24 | $16.2B | $882.0M | ||
| Q1 24 | $17.3B | $906.0M |
负债/权益比MPWOFIX
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.06× | 0.36× | ||
| Q2 25 | 2.00× | 0.34× | ||
| Q1 25 | 1.99× | 0.34× | ||
| Q4 24 | 1.83× | 0.31× | ||
| Q3 24 | 1.69× | 0.23× | ||
| Q2 24 | 1.51× | 0.22× | ||
| Q1 24 | 1.51× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 13.11× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MPWOFIX
| Q4 25 | $230.8M | $27.7M | ||
| Q3 25 | $18.6M | $12.4M | ||
| Q2 25 | $51.7M | $11.6M | ||
| Q1 25 | $384.0K | $-18.4M | ||
| Q4 24 | $245.5M | $23.7M | ||
| Q3 24 | $59.2M | $11.7M | ||
| Q2 24 | $35.3M | $9.0M | ||
| Q1 24 | $74.3M | $-18.6M |
自由现金流MPWOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率MPWOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度MPWOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率MPWOFIX
| Q4 25 | 13.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MPW
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
